Drug Profile
Research programme: recombinant vascular endothelial growth factor therapeutics and diagnostics - Trophogen
Alternative Names: TROP 005Latest Information Update: 28 Mar 2020
Price :
$50
*
At a glance
- Originator Trophogen
- Class Diagnostic agents; Recombinant proteins
- Mechanism of Action Diagnostic imaging enhancers; Vascular endothelial growth factor receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Mar 2020 No recent reports of development identified for preclinical development in Cancer in USA
- 28 Mar 2020 No recent reports of development identified for preclinical development in Cancer(Diagnosis) in USA
- 04 Feb 2016 Preclinical trials in Cancer (Diagnosis) in USA (unspecified route) before February 2016